TGA Approval

SANDOSTATIN Octreotide 50 microgram/1mL injection ampoule (42192)

ARTG ID

42192

ARTG Name

SANDOSTATIN Octreotide 50 microgram/1mL injection ampoule

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

January 5, 1993

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-04831-3

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2009-PI-00283-3

Ingredient Name

octreotide

Empowering clinical research with data-driven insights and AI-powered tools.

SANDOSTATIN Octreotide 50 microgram/1mL injection ampoule (42192) - TGA 批准文号 | MedPath